Business Context and Reporting Period
NeurAxis, Inc. filed a Form 8-K dated April 10, 2024, reporting the immediate termination of Dan Clarence, its Chief Operating Officer. The company is incorporated in Delaware, trades on the NYSE American under the symbol NRXS, and identifies as an emerging growth company.
Financial and Other Key Metrics
- Mr. Clarence’s employment agreement provides for salary-continuation severance at an annual base salary of $275,000 through October 10, 2024.
- The filing also requires the company to pay Mr. Clarence’s monthly COBRA premiums through October 10, 2025; the filing text does not provide the premium amount.
- The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating metrics.
Material Changes Versus the Prior Comparable Period
The filing reports a change in executive leadership: Dan Clarence ceased serving as Chief Operating Officer effective immediately on April 10, 2024. No successor or additional transition arrangements are disclosed.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- The company provides no financial guidance or operating outlook in this filing.
- The severance salary continuation and COBRA payments represent additional compensation obligations following the termination.
- The filing does not disclose the aggregate cost of the COBRA obligation, the reason for the termination, or any anticipated effect on operations.
Important Facts to Verify
- Whether NeurAxis has appointed or plans to appoint a replacement Chief Operating Officer.
- The total cash cost of salary continuation through October 10, 2024.
- The monthly COBRA premium and total potential obligation through October 10, 2025.
- Any subsequent disclosures regarding operational impact, leadership responsibilities, or related compensation changes.